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Abstract: Hepatic steatosis is a hallmark feature of kwashiorkor malnutrition. However,
the pathogenesis of hepatic steatosis in kwashiorkor is uncertain. Our objective was to develop
a mouse model of childhood undernutrition in order to test the hypothesis that feeding a maize
vegetable diet (MVD), like that consumed by children at risk for kwashiorkor, will cause hepatic
steatosis which is prevented by supplementation with choline. A MVD was developed with locally
sourced organic ingredients, and fed to weanling mice (n = 9) for 6 or 13 days. An additional group
of mice (n = 4) were fed a choline supplemented MVD. Weight, body composition, and liver changes
were compared to control mice (n = 10) at the beginning and end of the study. The MVD resulted
in reduced weight gain and hepatic steatosis. Choline supplementation prevented hepatic steatosis
and was associated with increased hepatic concentrations of the methyl donor betaine. Our findings
show that (1) feeding a MVD to weanling mice rapidly induces hepatic steatosis, which is a hallmark
disturbance of kwashiorkor; and that (2) hepatic steatosis associated with feeding a MVD is prevented
by choline supplementation. These findings support the concept that insufficient choline intake may
contribute to the pathogenesis of hepatic steatosis in kwashiorkor.
Keywords: kwashiorkor; malnutrition; hepatic steatosis; fatty liver disease; choline; betaine;
methionine; trimethylamine N-oxide (TMAO); one carbon metabolism; methylation
1. Introduction
Undernutrition is a leading cause of child mortality that contributes to the death of more than
1.3 million children every year [1]. The edematous syndrome of kwashiorkor is particularly lethal,
with mortality as great as 55% among affected children who require hospitalization [2]. Although
undernutrition is typically classified by causal deficiency, i.e., protein-energy or micronutrient
deficiencies, the cause of kwashiorkor remains unclear [3]. The defining organ level disturbance
of kwashiorkor is severe hepatic steatosis [4], leading early investigators to propose that kwashiorkor
be named “infantile fatty liver disease of the tropics” [5]. It was formerly believed that hepatic steatosis
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in kwashiorkor was due to inadequate protein intake resulting in decreased synthesis of the lipoprotein
components of very low density lipoprotein (VLDL), the primary vehicle of lipid export from the
liver [6]. However, recent evidence does not support this notion [7], and the cause of hepatic steatosis in
kwashiorkor remains uncertain [8]. The inherent complexity of assessing nutritional status in children
with kwashiorkor contributes to the uncertainty regarding the nutritional deficiencies that contribute
to its pathogenesis. For instance, children with kwashiorkor are often affected by diarrhea, [9],
which limits the absorption of essential nutrients that are marginally present in the plant based diets
associated with kwashiorkor, such as indispensable amino acids [10,11]. To better investigate the effects
of diets associated with kwashiorkor at a mechanistic level, we developed an experimental model
produced by feeding weanling mice a maize vegetable diet (MVD), comprised of foods consumed by
children with kwashiorkor [12]. This approach is an effort to realistically model the multiple nutritional
inadequacies experienced by children at risk for kwashiorkor in a controlled environment, without the
additional confounding influence of separate illnesses. In this pilot investigation, we characterized
the progressive impact of the MVD on growth and hepatic steatosis, with emphasis on the impact
of choline supplementation. The pathogenesis of hepatic steatosis that occurs in association with
maize based diets is relevant for understanding the entire kwashiorkor syndrome of malnutrition
because hepatic steatosis is its initial hallmark organ level disturbance, which occurs before the onset
of the syndromes’ diagnostic feature, edema. Our interest in choline supplementation stems from
two observations: that inadequate choline intake is associated with hepatic steatosis [13,14], and that
maize-based diets provide little choline [10]. Hepatic steatosis resulting from dietary choline deficiency
reflects choline’s essential role in the synthesis of phosphatidylcholine (PC), which is necessary for
lipid loading and export of hepatic VLDL [15]. Dietary choline supports PC synthesis by two different
pathways: directly through its activation and condensation with diacylglycerol to generate PC in
the Kennedy pathway [16], and indirectly through its oxidation to betaine, a methyl donor that
supports the synthesis of PC by increasing the availability of methyl groups [17], which are necessary
for the methylation of phosphatidylethanolamine to PC catalyzed by phosphatidylethanolamine
N-methyltransferase (PEMT) [18,19]. Hepatic steatosis in undernutrition may also reflect reduced
mTOR signaling, which supports growth and is necessary for phosphatidylcholine and triglyceride
secretion [20]. In this pilot investigation, we focused on identifying the metabolic consequences of
adding choline to a MVD fed to weanling mice. Specifically, we assessed the influence of choline
supplementation on hepatic lipid content, the hepatic concentration of certain metabolites related to the
availability and metabolism of methyl (CH3) groups, (henceforth referred to collectively as one carbon
metabolism), and the hepatic abundance of transcripts related to hepatic lipid export and catabolism:
(phosphatidylethanolamine N-methyltransferase (PEMT), apolipoprotein-B100 (ApoB100), peroxisome
proliferator activated receptor alpha (PPAR-α), and carnitine palmitoyl transferase 1a (CPT1a)).
2. Materials and Methods
2.1. Murine Diet
A murine diet similar to the weaning diets consumed by children who are at risk for kwashiorkor
was constructed using previously published nutritional survey data obtained from caregivers for
239 Malawian children (145 kwashiorkor, 46 marasmus, and 48 healthy controls) [12]. Among the
53 food items surveyed, 7 foods were selected for inclusion in the murine diet (Table 1) based on their
predominance in the diets consumed by children with kwashiorkor. USDA certified organic ingredients
used to prepare the murine diet were purchased locally in Houston, TX. The boiled maize porridge and
vegetable components of the murine diet were prepared separately according to local cooking practices
in Malawi. Specifically, organic yellow maize meal (Arrowhead Mills™) was combined with water,
brought to a boil, and simmered for 40 min while sugar and non-iodized salt were stirred in [21,22].
Chopped vegetables were boiled for 20 min, drained of excess water, combined with raw mango
pulp and bananas, and then homogenized in a commercial blender. The resulting vegetable–fruit
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purée was blended thoroughly with the cooked maize porridge in a commercial mixer. The resulting
homogenized slurry of maize porridge, boiled vegetables, and raw fruit was then stored at −5 ◦C
in one-gallon aliquots prior to lyophilization. Preparation of this novel murine MVD, including
lyophilization, was carried out in strict accordance with food industry practices to minimize the risk of
bacterial contamination. Samples of the lyophilized diet and control rodent chow were submitted to
NP Analytical Laboratories (St. Louis, MO, USA) for nutrient analysis (Table 2 and Table S1). Betaine
content was measured separately in laboratories at Cornell University, Ithaca New York.
Table 1. Ingredient composition of the maize-vegetable diet (MVD) before lyophilization.








Raw cane sugar 155
Table 2. Nutrient composition * of lyophilized maize vegetable diet and Teklad 2020X™ control chow.
Maize Vegetable Diet Control Chow MVD% of Control Chow
Metabolizable Energy,
kcal/kg 3693 3683 100.3
Protein, g/kg 64 183 35.0
Carbohydrate, g/kg 784 581 134.9
Fat, g/kg 34 71 47.9
Fiber, g/kg 15 28 53.6
Ash, g/kg 40 41 97.6
Moisture, g/kg 64 97 66.0
One Carbon Micronutrients and Sulfur Amino Acids
Choline, mg/kg 489 1620 30.2
Betaine, mg/kg 240 900 26.7
Folic Acid, mg/kg 0.15 2.46 6.1
Pyridoxine, mg/kg 2.46 11.9 20.7
Cysteine, mg/kg 1150 3700 31.1
Methionine, mg/kg 1020 4600 22.2
* Analyzed by NP Analytical Laboratories, St. Louis, Missouri.
2.2. Animals
Study animals were weanling mice (FVB/N) born to second and third parity dams fed a
semi-purified control diet based on AIN 93G [23], (20% protein; Research Diets, New Brunswick,
NJ, USA) during gestation and lactation. Weanling mice (11 female and 11 male) were selected for
study on post-natal day 21. All experiments were conducted in accordance with the Guide for the Care
and Use of Laboratory Animals. The study protocol was approved by the Institutional Animal Care
and Use Committee at Baylor College of Medicine.
2.3. Animal Protocol
The mice were divided into three separate dietary groups: (1) control chow (CON; Teklad Global
Soy Protein-Free Extruded Rodent Diet (2020X), Envigo; n = 10); (2) unsupplemented MVD (total
n = 10); and (3) choline supplemented MVD (MVD + C; n = 4). The MVD + C was constructed by
adding 1.4 g of choline bitartrate (Hard Eight Nutrition™) to each kg of the MVD, for a total choline
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concentration of 1.89 g/kg MVD + C diet. This level of choline supplementation was selected due
to its similarity to the amount of choline used in prior demonstrations that choline prevents hepatic
steatosis in animals subjected to low protein diets [24,25]. In order to assess the progressive effects of
feeding the MVD, mice fed the unsupplemented MVD were studied after 6 days (MVD-6; n = 5) and
13 days (MVD-13; n = 5). MVD + C mice were studied after nine days. CON mice were studied on
day 13. Mice were weighed at the beginning and end of the experiment.
2.4. Food Intake
All diets were ground into a powder using the same commercial grade food processor. Food
intake for all mice was measured using the same the same monitoring system: all mice were housed
individually in monitored units (Comprehensive Laboratory Animal Monitoring System™ (CLAMS)
Columbus Instruments, Columbus, OH, USA). This system was used to precisely monitor the amount
of food consumed by each mouse while also accounting for spillage, which was collected in a larger
tray located beneath the main food cup, which rested on the same balance used to quantify the amount
of food removed from the cup. Food and water were available ad libitum throughout the study. Room
temperature was maintained at 23.5 ◦C with a 12 h light/dark cycle. Food intake data was collected
using the CLAMS recording system, and together with the energy density values (Table 2), was used
to calculate energy intake. Weight adjusted energy intake was calculated by dividing the total Kcal
consumed by the animal’s mean body weight and the number of days the animal was studied, i.e.,
kcal/g BW.day. Daily weight adjusted food intake was calculated similarly using the total weight
of food consumed, i.e., g/g BW.day. Feed efficiency was calculated by dividing each animals’ total
weight gain by the weight of food consumed throughout the study.
2.5. Body Composition
A quantitative magnetic resonance (QMR) analyzer (Echo Medical, Houston, TX, USA) was used
to measure total body fat and lean mass on study day one and before euthanasia. This data was used
to calculate daily lean and fat mass gain. At the end of the study, mice were anesthetized deeply
with isoflurane before decapitation. Hepatic tissue was harvested immediately, snap frozen in liquid
nitrogen, and stored at−80 ◦C until analyzed. The right hepatic lobe of each liver was fixed in formalin,
paraffin-embedded, and 4 µm liver sections were cut, processed, and stained with hematoxylin and
eosin (H&E) for light microscopy examination following standard procedures. Samples of frozen liver
were cryosectioned (10 µM) onto glass slides, fixed in 10% formaldehyde, and stained for lipid with
Oil Red O, followed by H&E and a final immersion in toluidine blue and basic fucsin stain before
mounting in aqueous glycerin jelly media. Photometric assessment of the amount of Oil Red O stained
lipid material present in liver tissue was performed using a customized MATLAB™ algorithm. Briefly,
digital images of liver tissue were converted into a MATLAB™ format consisting of three separate
color spectrums: red, grey, and blue. Each pixel was then cross referenced with a reference histologic
material; (i.e., lipid, (red), vacant background (grey), or nucleic material, (blue)), which allowed
quantification of lipid droplets in each liver tissue specimen. Periodic acid Schiff (PAS) staining of
liver tissue for light microscopy was undertaken using 5 µm sections of liver tissue that were first
deparaffinized and hydrated in water before placement in 0.5% periodic acid solution for 5 min. Tissue
sections were then rinsed in distilled water and placed in Schiff reagent for 15 min before rinsing
in tap water. Sections were counterstained in Mayer’s hematoxylin for one minute, dehydrated in
alcohol, and then covered using a synthetic mounting medium. Histologic examination of liver tissue
specimens were conducted in the pathology laboratories at Texas Children’s Hospital, Houston, Texas,
by a pathologist who remained blinded to the dietary treatments.
2.6. Metabolite Concentrations
Liver samples from MVD-fed mice (MVD-6, n = 4; MVD-13, n = 4), MVD + C mice (n = 3), and
CON mice (n = 3) were available for further metabolite and transcriptional analyses. To measure
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the concentration of methionine and choline-related metabolites in liver, samples (0.02–0.05 g) were
homogenized (Argos Technologies Pestle Motor Mixer A0001) in 400 µL of 2:1 methanol/chloroform.
Metabolite concentrations in the liver homogenates and in-house controls were measured using
established LC–tandem MS methods reported previously [23], with minor protocol adaptations
allowing use of local instrumentation. All metabolite measurements were made on the same day using
the same LC-tandem MS machinery and setup. Homogenized liver tissue specimens from healthy
adult mice with defined metabolite concentrations were used as quality control samples. The assay
imprecision (i.e., coefficient of variation), was <5% for betaine, free choline, and dimethylglycine, and
8.8% for methionine. All metabolite data were generated in laboratories at Cornell University, Ithaca,
New York.
2.7. mRNA Quantification by Quantitative Reverse-Transcriptase (RT) PCR
RNA was extracted from frozen liver samples from MVD (MVD-6, n = 3; MVD-13, n = 3), MVD + C
(n = 3), and CON mice (n = 3). Total RNA was extracted with Trizol reagent (Invitrogen™, Carlsbad,
CA, USA) using the manufacturer’s protocol. RNA concentration and quality were assessed using a
NanoDrop ND-1000 spectrophotometer. cDNA was generated using a high capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA, USA, Thermo Fisher Scientific, Waltham, MA,
USA) and an Eppendorf 5331 Mastercycler. Quantitative PCR was performed with a BioRad C-1000
Touch Thermal Cycler using SYBR Green Supermix reagents (Bio-Rad Laboratories, Hercules, CA,
USA). Primers used in this investigation (i.e., ß-glucuronidase [Gusb], PEMT, ApoB, PPAR-α, and
CPT1a), were identified from the literature and confirmed using the NCBI Primer-BLAST algorithm.
Forward and reverse primer sequences are shown in Supplementary Table S2. Primer efficiencies were
calculated (1.8–2.2) following amplification of a standard curve. Melting curves were included at the
end of amplification cycles to validate specificity of the PCR product. The 2−∆Ct method was used to
calculate fold changes normalized to the expression of the housekeeping gene, β-glucuronidase (Gusb).
2.8. Statistical Analyses
The normality and homogeneity of generated data were confirmed using a Kolmogorov–Smirnov
test [26] and Levene’s test [27], respectively. Due to group size asymmetry, a Welch’s ANOVA [28] was
paired with a Tukey honest significant difference (HSD) [29] post hoc analysis with a confidence level
of 0.95 (p < 0.05) in order to measure intergroup differences for feeding and metabolite data. Statistical
analysis of transcriptional data was performed using R (version 3.4.0), with differences assessed using
a standard one-way ANOVA. Data are presented as means ± SE.
3. Results
3.1. Comparison of Study Diets
Although the energy density of the MVD was nearly identical to that of regular chow,
macronutrient analysis demonstrated that the MVD contained a disproportionately larger amount of
carbohydrate at the expense of protein and fat. Specifically, the MVD contained 35, 49, and 135% of
the protein, fat, and carbohydrate present in regular chow, respectively (Table 2). The concentration
of all measured minerals and micronutrients, with the exception of sodium, were significantly lower
in the MVD (Table S1). The sodium content of the MVD is a reflection of the addition of non-iodized
salt during preparation of the MVD, in accordance with prevailing culinary practices in Sub-Saharan
Africa [24]. Consistent with the reduced protein content of the MVD, the concentration of individual
amino acids in the MVD ranged from 22% to 43% of the amount present in the regular chow diet.
With regard to the comparative content of nutrients that support one carbon metabolism, the MVD
provided 22% of the methionine content, 30% of the choline content, 26% of the betaine content, and
6% of the folate content of regular chow.
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3.2. Weight Gain and Feed Intake
Compared to CON mice, MVD fed mice had lower daily weight gain, (p < 0.01; Figure 1A), with
MVD + C mice exhibiting the most pronounced effect. Daily lean gain was significantly lower in all
MVD-fed mice compared to CON; (p < 0.01; Figure 1B). All three MVD diets exhibited lower daily
fat mass gain (p < 0.05; Figure 1C), than mice fed CON chow. This effect was most pronounced in
MVD + C mice, which lost total fat mass despite gaining total weight and lean mass. In MVD6 and
MVD13 groups of mice there was a largely non-significant trend of weight adjusted food and energy
intake that was greater than that of control mice, whereas in MVD + C mice there was a non-significant
opposite trend (Figure 1D,E). All MVD-fed mice had feed efficiencies that were significantly less than
that of controls (Figure 1F). This effect was most pronounced in MVD + C mice.
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Figure 1. Weight gain, composition of weight gain, and food intake parameters of weanling mice fed
a control chow diet (n = 10), the maize vegetable diet (MVD) for 6 days (MVD-6; n = 5) or 13 days
(MVD-13; n = 5), or 9 days with a MVD supplemented with choline (MVD + C; n = 4). (A) daily weight
gain; (B) daily lean mass gain; (C) daily fat mass gain; (D) daily weight-adjusted food intake; (E) daily
weight-adjusted energy intake; and (F) feed efficiency. Presence of a statistically significant difference
between data points (p < 0.05) is designated by the absence of a shared lowercase letter over the data
point. Bars represent mean values ± SE.
3.3. Histology
The most prominent finding was noted on microscopic examination of Oil Red O stained
liver tissue, which demonstrated the pronounced accumulation of lipids in hepatocytes in MVD-6
and MVD-13 mice (relative to chow fed mice) (Figure 2A,B,D). The absence of this phenotype in
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MVD + C mice (Figure 2C) is consistent with our hypothesis that choline supplementation prevents
the development of hepatic steatosis in weanling mice subjected to a MVD. Quantitative assessment
of hepatic lipid depositions using photometric tools confirmed the statistical significance of this
observation (Table S3). Direct comparison of lipid localization within the three separate zones of the
portal triad in MVD-fed mice did not reveal a specific distribution pattern. Rather, lipid droplets
were located evenly throughout the three zones of the hepatic lobule. Although there were significant
accumulations of hepatic lipids in mice fed the unsupplemented MVD, there was no evidence of
inflammation on H&E sections. PAS stained liver tissue from MVD + C mice (Figure 3C) was not
different CON mice (Figure 3D), with a similar abundance and distribution of PAS stained material
located primarily in zone three. Liver tissue from both groups of mice fed an unsupplemented MVD
(Figure 3A,B) was nearly free of PAS stained material.
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chow for 13 days.
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Figure 3. Periodic acid Schiff (PAS) stained liver tissue (20×, scale bar represents 20 µm) collected from
mice fed maize vegetable diet (MVD) diets or chow. Bright red staining areas indicate the presence
of polysaccharides; dark blue staining indicates nuclear material. (A) Liver section from mouse fed
the unsupplemented MVD for 6 days; (B) liver section from mouse fed the unsupplemented MVD for
13 days; (C) liver section from mouse fed the MVD supplemented with choline for 9 days; and (D) liver
section from a control mouse fed chow for 13 days.
3.4. Liver Metabolites
Quantification of the hepatic concentration of methionine, choline, and the choline-related
metabolites betaine and dimethylglycine, provided insight into the hepatic metabolism of choline in
the different groups of mice. Whereas the mean hepatic concentration of methionine was similar in
CON, MVD-6, and MVD-13 groups, hepatic methionine was significantly lower in MVD + C mice
(Figure 4A and Table S3). Hepatic choline was significantly lower in all MVD fed mice, including
MVD + C, relative to chow (Figure 4B), whereas hepatic betaine (produced from the oxidation of
choline [30]), was highest in mice fed the MVD + C diet (p < 0.05; Figure 4C). Hepatic dimethylglycine,
which is produced from the demethylation of betaine, was lower (p < 0.05) in both groups of mice fed
an unsupplemented MVD, to both chow and MVD + C mice (Figure 4D). Trimethylamine N-oxide
(TMAO), a plasma metabolite which is increased when dietary choline is metabolized by the gut
microbiome [25], was significantly elevated in MVD + C mice (p < 0.05; Figure 4E).
3.5. Transcriptional Targets
The results of RT-qPCR analyses were notable for a trend of greater transcription of ApoB
(p = 0.059), in MVD + C mice (Figure S1).
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micronutrients result in growth stunting despite adequate energy content [32]. The pattern of reduced
total weight gain in MVD-fed mice relative to CON mice was reflected by both lower lean and fat mass
gains. The lower weight gain of MVD + C mice relative to mice in the unsupplemented MVD groups
was attributable to decreased fat gain. This observation corresponds with recent demonstrations that
choline deficiency is associated with impaired lipid metabolism [26], and that choline supplementation
promotes molecular shifts associated with increased fat catabolism [27–29,33]. However, decreased
fat gain was not observed in mice consuming the control diet, which also provided ample amounts
of choline, suggesting that the metabolic effects of choline is unique in the context of the MVD. The
observation of reduced fat gain in MVD + C mice warrants further exploration in studies utilizing
stable isotopes and systems biology approaches.
The primary hypothesis of this investigation was that feeding weanling mice a diet similar to
that consumed by children at risk for kwashiorkor will result in hepatic steatosis, which is a hallmark
pathophysiologic feature of kwashiorkor [30]. We documented that mice fed the unsupplemented
MVD developed significant hepatic steatosis within six days of consuming the MVD (Figure 2). There
was no evidence of steatohepatitis, an inflammatory sequelae of nonalcoholic fatty liver disease
(NAFLD) that is closely correlated with the duration of steatosis. This is likely a reflection of the
relatively short time-frame that mice were exposed to the steatogenic unsupplemented MVD. This
pattern of hepatic steatosis corresponds with the findings of a similarly constructed porcine model
of malnutrition [34]. We also demonstrated that PAS stained hepatic tissue from mice that were fed
an unsupplemented MVD had reduced quantities of PAS staining material relative to CON mice,
consistent with a limited presence of glycogen. This pattern of PAS staining reflects of the complex
metabolic disturbances precipitated by the MVD, which also reduced hepatic glycogen stores.
Additional efforts were directed towards understanding the role of one carbon metabolism
disturbances in the pathogenesis of hepatic steatosis precipitated by feeding the MVD. One carbon
metabolism disturbances are often associated with NAFLD due to the fact that loading of triglycerides
into VLDL and the hepatic secretion of VLDL require phosphatidylcholine (PC) synthesized by the
methylating action of PEMT [35]. The association between NAFLD and one carbon metabolism
disturbances is relevant for understanding the pathogenesis of hepatic steatosis in undernutrition
because inadequate intake of nutrients essential for one carbon metabolism often leads to decreased
hepatic PC synthesis by the PEMT pathway, resulting in hepatic steatosis as a consequence [36,37]
(Figure 5). Notably, the MVD contained smaller quantities of several nutrients that are essential for
maintaining the availability of labile one-carbon molecules (Table 2). In addition to containing only
a third as much methionine as control chow, the MVD provided smaller quantities of the methyl
donors, folate and betaine, as well as the essential precursor of betaine, choline. This pattern of
nutrient depletion in the MVD is similar to that of experimental diets designed to precipitate hepatic
steatosis [38,39].
Although it is known that choline supplementation prevents hepatic steatosis associated with
established low protein diet models of undernutrition [40], it was not known whether increased
choline intake would alone be sufficient to prevent hepatic steatosis associated with an MVD, which
is deficient in multiple nutrients essential for one carbon metabolism. Therefore, we chose to focus
on the metabolic fate of supplemental choline in this initial investigation of the MVD. Although it is
clear that the nutritional deficiencies that cause kwashiorkor are more complex than simple choline
deficiency, a greater understanding of choline’s role in the pathogenesis of hepatic steatosis associated
with kwashiorkor carries the potential to guide the development of strategies to prevent kwashiorkor
in children. The finding that MVD + C mice had significantly greater hepatic concentrations of
betaine, but not choline (Figure 4C), suggests that supplemental choline was readily oxidized to the
methyl donor betaine. Similarly, hepatic concentrations of dimethylglycine, which is formed from
the demethylation of betaine, were higher in MVD + C mice, compared to both unsupplemented
MVD groups (Figure 4D), indicating that choline supplementation increased the hepatic availability of
methyl groups. Notably, increased hepatic availability of the methyl donor betaine in MVD + C mice
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was associated with significantly lower hepatic concentrations of methionine (Figure 4A). Although
methionine is critical for the formation of the universal methyl donor S-adenosylmethionine [41], which
is necessary for PEMT activity [42] and VLDL export [18] from hepatocytes (Figure 5), reduced hepatic
methionine in MVD + C mice was not associated with steatosis. The demonstration of decreased
hepatic methionine without steatosis suggests that choline supplementation promoted more efficient
methionine use in the context of the MVD.
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Our demonstration of greater hepatic TMAO concentrations in choline supplemented mice
(Figure 4E) is consistent with the fact that increased choline intake leads to increased availability of
choline for metabolism by the gut microbiome, thus promoting the formation of TMAO [43]. Although
increased TMAO has been associated with hepatic steatosis in humans [44], this was not the case in
this investigation. Rather, MVD + C mice, which had the greatest concentrations of hepatic TMAO, did
not develop steatosis. This finding is notable given the well described association between increased
plasma TMAO and the risk for various metabolic disease states [45] closely associated with hepatic
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steatosis and suggests that increased TMAO does not by itself cause the pathogenesis of hepatic
steatosis in undernutrition. The observation that TMAO levels were increased in the MVD + C mice
but not chow mice, which consumed similar levels of choline, suggests that the short term feeding of
the MVD altered TMAO handling. Future studies examining the composition of the gut microbiome,
kinetics of TMAO metabolism, influence of TMAO on hepatic inflammation, as well as urinary and
fecal excretion of TMAO, are warranted.
The observed trend of greater apolipoprotein-B100 transcription in mice consuming the
MVD + C diet (p = 0.059), suggests that choline supplementation also supported greater synthesis of
apolipoprotein-B100, an essential component of VLDL, which is the primary vehicle of lipid export
from the liver [46]. However, larger sample sizes are necessary to precisely characterize the molecular
effects of choline supplementation in this novel undernourished mouse model.
Our study was constrained by limitations that are important to consider. While the obtained
metabolic data are relevant to hepatic PC synthesis, the small quantity of hepatic tissue available for
analyses in this initial investigation limited our ability to quantify PC and PC subspecies. Similarly,
the interpretability of transcriptional data was limited by the small number of tissue specimens
available for analysis in this initial study, and also by the fact that transcriptional content is not
necessarily a reliable proxy for the amount of protein translated. In addition to supporting PC
synthesis through the PEMT pathway, choline also supports the direct synthesis of PC by the cytidine
diphosphate (CDP)-choline pathway [16]. Although increased CDP-choline pathway activity is likely
to have been metabolically relevant in MVD + C mice, accurate measurement of CDP activity requires
stable isotope techniques that are beyond the scope of this initial study. Larger studies using isotopically
labeled choline [47] are likely to provide more precise insight for understanding the predominant
mechanism by which choline supplementation prevented hepatic steatosis in this novel mouse model
of undernutrition.
5. Conclusions
In summary, feeding weaning mice a diet composed primarily of maize and vegetables that
is similar to the diets consumed by children at risk for kwashiorkor resulted in hepatic steatosis,
a defining organ level disturbance of kwashiorkor [30]. Notably, hepatic steatosis developed in as
little as six days and was prevented by choline supplementation alone, without supplementing with
other essential one carbon nutrients such as folate or methionine, which like choline were minimally
present in the MVD. Metabolic data suggested that the prevention of hepatic steatosis in mice fed a
choline-supplemented MVD was associated with a significant increase in the hepatic availability of
methyl groups. This finding is consistent with the observation that VLDL export from the liver has an
absolute requirement for PC synthesized by PEMT [35,48] a methyl group dependent enzyme. Overall,
these findings provide insight into the molecular mechanisms influenced by the addition of choline to
a MVD, and highlight the potential role of one-carbon nutrients, such as choline, for preventing hepatic
steatosis in children subsisting on low protein plant based diets that are associated with increased risk
for kwashiorkor malnutrition.
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